Acquisitions23 May 2026, 09:00 pm
Anupam Rasayan to Acquire 43.3-48.2% Stake in Bliss GVS
AI Summary
Anupam Rasayan India Ltd has entered into a definitive agreement to acquire a 43.3-48.2% equity stake in Bliss GVS Pharma Limited, followed by an open offer to public shareholders. The acquisition will be financed through ₹300 Crores via Term Loan and a non-controlling, non-voting equity instrument for the balance. This move aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from KSMs to finished dosage formulations, leveraging Bliss GVS Pharma's capabilities in niche dosage forms and international market presence.
Key Highlights
- Anupam Rasayan to acquire 43.3-48.2% stake in Bliss GVS Pharma.
- Acquisition includes an open offer to Bliss GVS Pharma's public shareholders.
- The deal will be funded by ₹300 Cr term loan and equity instruments.
- Bliss GVS Pharma has EU-GMP certified manufacturing facilities in India.
- Acquisition aims to create an integrated global life sciences platform.